glp 1 lily Eli Lilly to seek approval of new GLP-1 weight-loss drug this year Lilly says its experimental GLP-1

slow degradability over time (Wen et al., 2017)

doi: 10.1111/jpn.12979 13

Growth Factors 2006

Melanotan-2: The Shotgun Approach MT-2 hits the same MC1R receptor but also activates MC3R, MC4R, and MC5R : MC1R Melanin production (tanning) MC3R Energy homeostasis, cardiovascular function MC4R Sexual arousal, appetite regulation, erectile function MC5R Exocrine gland function, sebaceous secretion This non-selective binding is why MT-2 causes the "side effects" that many users actually seek out particularly the libido and appetite suppression effects

That's the appeal

Kidney disease and renal impairment represent significant concerns